Back

Prognostic value of a non-invasive haemodynamic congestion index and traffic-light risk score for 90-day non-elective hospitalisation following right-heart catheterisation

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Risk stratification in heart failure Epidemiology, Prognosis, Outcome Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Andrew Sauer

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

6 More presentations in this session

Presentation thumbnail
Mortality accuracy of artificial intelligence and machine learning models in patients with heart failure: a systematic review
Doctor C. Vigil Lopez (Ensenada, MX)
Abstract Slides Video
Presentation thumbnail
The obesity paradox in heart failure: insights from a nationwide multi-ethnic Asian cohort
Doctor S. Jauhari (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Synthetic data as a tool to quantify heart failure hospitalization burden
Doctor K. Haichin (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Endothelial Activation and Stress Index (EASIX) Predicts In-Hospital Mortality in Acute Decompensated Heart Failure with Reduced Ejection Fraction
Doctor B. Cuvalcioglu (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Plasma neurofilament light is associated with cognitive impairment in patients hospitalized for heart failure
Doctor A. Yaghoubi (Malmoe, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in heart failure

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Presentation
Incremental prognostic value of ultrasound-based assessment of residual congestion at discharge after acute heart failure hospitalization
thumbnail
Congress Presentation
Stratification of patients with heart failure referred to cardiology at higher risk of 1-year heart failure admission or mortality by a machine learning algorithm
thumbnail
Congress Presentation
Hemodynamic profiles and survival in chronic advanced heart failure patients evaluated for heart replacement therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources